LXXGF News and Press, Lexagene Holdings From 06/10/21

MiQLab detects 100% of C. acnes samples 36-times faster than a culture started from ideal laboratory conditions (in 2 hours versus 3 days) MiQLab can be as much as 168-times faster than a culture started from a bioreactor sample (2 hours versus 14 days) Adopting MiQLab...

MiQLab detects 100% of C. acnes samples 36-times faster than a culture started from ideal laboratory conditions (in 2 hours versus 3 days) MiQLab can be as much as 168-times faster than a culture started from a bioreactor sample (2 hours versus 14 days) Adopting MiQLab could...

LexaGene (TSX.V: LXG) (OTCQB: LXXGF) , a molecular diagnostics company that develops fully automated rapid pathogen detection systems, has received a purchase order for its exclusive MiQLab System(TM) from Denver Animal Emergency. The North Carolina emergency medicine and compassionate...

BEVERLY, Mass., June 07, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “ Company ”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce Denver Anima...

LexaGene Holdings (LXXGF) has partnered with Ethos Discovery to develop new companion animal diagnostic tests.The company's first validated panel, MiQLab Bacterial and AMR Test, was developed specifically for aiding in the diagnosis of urinary tract infections ((UTI)), one of the most co...

BEVERLY, Mass., June 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it has partn...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 1, 2021 – As the world shut down and everyone isolated at home, social distancing became the new norm. While it was an important public health measure that saved lives, it also cont...

BEVERLY, Mass., June 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it is taking...

LexaGene Holdings (TSXV: LXG) (OTCQB: LXXGF) , a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced the hiring of four additional sales representatives, including three for the veterinary market and one for the contract drug manufac...

BEVERLY, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce the hiring of...